{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:28:57Z","timestamp":1792841337301,"version":"4.5.0"},"reference-count":216,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.pharmthera.2021.108047","type":"journal-article","created":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T19:02:07Z","timestamp":1638039727000},"page":"108047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["HIV-associated neurotoxicity and cognitive decline: Therapeutic implications"],"prefix":"10.1016","volume":"234","author":[{"given":"David R.","family":"Wallace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pharmthera.2021.108047_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037540","article-title":"Soy isoflavones genistein and daidzein exert anti-apoptotic actions via a selective ER-mediated mechanism in neurons following HIV-1 Tat(1-86) exposure","volume":"7","author":"Adams","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0010","article-title":"Nano-based drug delivery system: A smart alternative towards eradication of viral sanctuaries in management of NeuroAIDS","author":"Aggarwal","year":"2021","journal-title":"Drug Delivery and Translational Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108047_bb0015","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.nbd.2011.10.005","article-title":"HIV-1 Tat neurotoxicity: A model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes","volume":"45","author":"Agrawal","year":"2012","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2009.09.113","article-title":"Dopaminergic neurotoxicity of HIV-1 gp120: Reactive oxygen species as signaling intermediates","volume":"1306","author":"Agrawal","year":"2010","journal-title":"Brain Research"},{"issue":"12","key":"10.1016\/j.pharmthera.2021.108047_bb0025","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.2174\/1568026621666210412152428","article-title":"Natural bioactives as a potential therapeutic modality against NeuroAIDS","volume":"21","author":"Ahmed","year":"2021","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108047_bb0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2990.2011.01215.x","article-title":"Activation status of integrated stress response pathways in neurones and astrocytes of HIV-associated neurocognitive disorders (HAND) cortex","volume":"38","author":"Akay","year":"2012","journal-title":"Neuropathology and Applied Neurobiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0035","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11481-012-9362-3","article-title":"D1\/NMDA receptors and concurrent methamphetamine+ HIV-1 Tat neurotoxicity","volume":"7","author":"Aksenov","year":"2012","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(01)01786-4","article-title":"Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum","volume":"305","author":"Aksenov","year":"2001","journal-title":"Neuroscience Letters"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(03)03194-9","article-title":"Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum","volume":"987","author":"Aksenov","year":"2003","journal-title":"Brain Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108047_bb0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11481-019-09885-8","article-title":"Inhibition of the dead box RNA helicase 3 prevents HIV-1 Tat and cocaine-induced neurotoxicity by targeting microglia activation","volume":"15","author":"Aksenova","year":"2020","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1567202052773463","article-title":"Cell culture models of oxidative stress and injury in the central nervous system","volume":"2","author":"Aksenova","year":"2005","journal-title":"Current Neurovascular Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2021.108047_bb0060","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4161\/auto.6805","article-title":"Decreased neuronal autophagy in HIV dementia: A mechanism of indirect neurotoxicity","volume":"4","author":"Alirezaei","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008249","article-title":"Cross-talk between microglia and neurons regulates HIV latency","volume":"15","author":"Alvarez-Carbonell","year":"2019","journal-title":"PLoS Pathogens"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0070","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2174\/1570162X12666140526122709","article-title":"Heme oxygenase-1 dysregulation in the brain: Implications for HIVAssociated neurocognitive disorders","volume":"12","author":"Ambegaokar","year":"2014","journal-title":"Current HIV Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108047_bb0075","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1212\/WNL.41.6.778","article-title":"Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force","volume":"41","author":"American Academy of Neurology AIDS Task Force","year":"1991","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0080","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-2006-956759","article-title":"Dementia and neurocognitive disorders due to HIV-1 infection","volume":"27","author":"Ances","year":"2007","journal-title":"Seminars in Neurology"},{"issue":"5","key":"10.1016\/j.pharmthera.2021.108047_bb0085","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s13365-020-00861-0","article-title":"Intersecting roles of ER stress, mitochondrial dysfunction, autophagy, and calcium homeostasis in HIV-associated neurocognitive disorder","volume":"26","author":"Andhavarapu","year":"2020","journal-title":"Journal of Neurovirology"},{"issue":"18","key":"10.1016\/j.pharmthera.2021.108047_bb0090","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders","volume":"69","author":"Antinori","year":"2007","journal-title":"Neuroology"},{"issue":"8","key":"10.1016\/j.pharmthera.2021.108047_bb0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1371\/journal.ppat.1002892","article-title":"Nonhuman primate models for HIV cure research","volume":"8","author":"Apetrei","year":"2012","journal-title":"PLoS Pathogens"},{"issue":"10","key":"10.1016\/j.pharmthera.2021.108047_bb0100","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1093\/jac\/dkv183","article-title":"Efavirenz and the CNS: What we already know and questions that need to be answered","volume":"70","author":"Apostolova","year":"2015","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108047_bb0105","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/jnc.14015","article-title":"The viral protein gp120 decreases the acetylation of neuronal tubulin: Potential mechanism of neurotoxicity","volume":"141","author":"Avdoshina","year":"2017","journal-title":"Journal of Neurochemistry"},{"issue":"7","key":"10.1016\/j.pharmthera.2021.108047_bb0110","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/QAD.0000000000002509","article-title":"HIV influences microtubule associated protein-2: Potential marker of HIV-associated neurocognitive disorders","volume":"34","author":"Avdoshina","year":"2020","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0115","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s13365-012-0144-8","article-title":"Detection of anti-tat antibodies in CSF of individuals with HIV-associated neurocognitive disorders","volume":"19","author":"Bachani","year":"2013","journal-title":"Journal of Neurovirology"},{"issue":"5","key":"10.1016\/j.pharmthera.2021.108047_bb0120","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1074\/jbc.M111.262543","article-title":"Up-regulation of the neuronal nicotinic receptor \u03b17 by HIV glycoprotein 120: Potential implications for HIV-associated neurocognitive disorder","volume":"287","author":"Ballester","year":"2012","journal-title":"Journal of Biological Chemistry"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2021.108047_bb0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0006-8993(00)02725-6","article-title":"Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum","volume":"879","author":"Bansal","year":"2000","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0130","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ijbiomac.2018.11.146","article-title":"The attenuation of HIV-1 Tat-induced neurotoxicity by Salvianic acid A and Danshen granule","volume":"124","author":"Bao","year":"2019","journal-title":"International Journal of Biological Macromolecules"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108047_bb0135","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/21691401.2017.1313266","article-title":"Intranasal chitosan-g-HP\u03b2CD nanoparticles of efavirenz for the CNS targeting","volume":"46","author":"Belgamwar","year":"2018","journal-title":"Artificial Cells, Nanomedicine, and Biotechnology"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108047_bb0140","doi-asserted-by":"crossref","DOI":"10.1177\/1759091416679073","article-title":"HIV glycoprotein Gp120 impairs fast axonal transport by activating Tak1 signaling pathways","volume":"8","author":"Berth","year":"2016","journal-title":"ASN Neuro"},{"issue":"5","key":"10.1016\/j.pharmthera.2021.108047_bb0145","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.mehy.2012.02.008","article-title":"HIV associated dementia: Role for neurosteroids","volume":"78","author":"Bhagavathi Perumal","year":"2012","journal-title":"Medical Hypotheses"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1750-3639.2004.tb00503.x","article-title":"Human immunodeficiency virus infection of the brain: Pitfalls in evaluating infected\/affected cell populations","volume":"14","author":"Bissel","year":"2004","journal-title":"Brain Pathology"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108047_bb0155","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3109\/13550280009091948","article-title":"CPI-1189 prevents apoptosis and reduces glial fibrillary acidic protein immunostaining in a TNF-alpha infusion model for AIDS dementia complex","volume":"6","author":"Bjugstad","year":"2000","journal-title":"Journal of Neurovirology"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0160","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3389\/fmicb.2015.01143","article-title":"HIV-1, methamphetamine and astrocytes at neuroinflammatory crossroads","volume":"6","author":"Borgmann","year":"2015","journal-title":"Frontiers in Microbiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/07853890.2020.1814962","article-title":"Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis","volume":"53","author":"Borrajo","year":"2021","journal-title":"Annals of Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108047_bb0170","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1084\/jem.20040874","article-title":"CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract","volume":"200","author":"Brenchley","year":"2004","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0175","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11481-015-9634-9","article-title":"Effect of HAART on brain organization and function in HIV-negative subjects","volume":"10","author":"Brier","year":"2015","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-021-02116-z","article-title":"The psychoactive drug of abuse mephedrone differentially disrupts blood-brain barrier properties","volume":"18","author":"Buzhdygan","year":"2021","journal-title":"Journal of Neuroinflammation"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108047_bb0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40265-016-0678-9","article-title":"Treating HIV infection in the central nervous system","volume":"77","author":"Calcagno","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0190","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neuropharm.2015.01.009","article-title":"Pharmacological induction of CCL5 in vivo prevents gp120-mediated neuronal injury","volume":"92","author":"Campbell","year":"2015","journal-title":"Neuropharmacology"},{"issue":"September","key":"10.1016\/j.pharmthera.2021.108047_bb0195","first-page":"1","article-title":"HIV neuroinfection and Alzheimer\u2019s disease: Similarities and potential links?","volume":"12","author":"Canet","year":"2018","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108047_bb0200","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/toxsci\/kfr239","article-title":"The role of environmental exposures in neurodegeneration and neurodegenerative diseases","volume":"124","author":"Cannon","year":"2011","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-8-48","article-title":"Lentiviral vector-mediated stable expression of sTNFR-Fc in human macrophage and neuronal cells as a potential therapy for neuroAIDS","volume":"8","author":"Cao","year":"2011","journal-title":"Journal of Neuroinflammation"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0210","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1471-4159.2006.03863.x","article-title":"The immunophilin ligand GPI1046 protects neurons from the lethal effects of the HIV-1 proteins gp120 and Tat by modulating endoplasmic reticulum calcium load","volume":"98","author":"Caporello","year":"2006","journal-title":"Journal of Neurochemistry"},{"issue":"8","key":"10.1016\/j.pharmthera.2021.108047_bb0215","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3390\/vaccines9080930","article-title":"Alzheimer\u2019s-like pathology at the crossroads of HIV-associated neurological disorders","volume":"9","author":"Chemparthy","year":"2021","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0220","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/COH.0b013e32835fc601","article-title":"Where does HIV hide? A focus on the central nervous system","volume":"8","author":"Churchhill","year":"2013","journal-title":"Current Opinion in HIV and AIDS"},{"issue":"16","key":"10.1016\/j.pharmthera.2021.108047_bb0225","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1212\/WNL.0b013e31821670fb","article-title":"Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients","volume":"76","author":"Ciccarelli","year":"2011","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.pharmthera.2021.108047_bb0230","first-page":"884","article-title":"Brain dysfunction in the era of combination antiretroviral therapy: Implications for the treatment of the aging population of HIV-infected individuals","volume":"11","author":"Clark","year":"2010","journal-title":"Current Opinion in Investigational Drugs"},{"issue":"10","key":"10.1016\/j.pharmthera.2021.108047_bb0235","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/01.WNL.0000034177.47015.DA","article-title":"A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment","volume":"59","author":"Clifford","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0240","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1126\/science.270.5243.1811","article-title":"Identification of RANTES, MIP-1alpha, and MIP-1beta as the major HIV-suppressive factors produced by CD8+ T cells","volume":"270","author":"Cocchi","year":"1995","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.pharmthera.2021.108047_bb0245","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.neuro.2005.01.019","article-title":"17\u03b2-estradiol reduces neuronal apoptosis induced by HIV-1 gp120 in the neocortex of rat","volume":"26","author":"Corasaniti","year":"2005","journal-title":"NeuroToxicology"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0250","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3390\/ijms10031045","article-title":"Molecular pathology of neuro-AIDS (CNS-HIV)","volume":"10","author":"Crews","year":"2009","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"10.1016\/j.pharmthera.2021.108047_bb0255","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.biochi.2007.04.009","article-title":"An open issue: The inner mitochondrial membrane (IMM) as a free boundary problem","volume":"89","author":"Demongeot","year":"2007","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11481-006-9051-1","article-title":"Glycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDS","volume":"2","author":"Dewhurst","year":"2007","journal-title":"Journal of Neuroimmune Pharmacology\u202f: The Official Journal of the Society on NeuroImmune Pharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2021.108047_bb0265","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1515\/hsz-2012-0119","article-title":"Mitophagy: Mechanisms, pathophysiological roles, and analysis","volume":"393","author":"Ding","year":"2012","journal-title":"Biological Chemistry"},{"issue":"00","key":"10.1016\/j.pharmthera.2021.108047_bb0270","first-page":"1","article-title":"HIV-1 Tat and cocaine impact mitochondrial epigenetics: Effects on DNA methylation","volume":"00","author":"Doke","year":"2020","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0275","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/019262330002800106","article-title":"An integrative approach to neurotoxicology","volume":"28","author":"Dorman","year":"2000","journal-title":"Toxicologic Pathology"},{"issue":"8","key":"10.1016\/j.pharmthera.2021.108047_bb0280","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00415-017-8503-2","article-title":"HIV-1-associated neurocognitive disorder: Epidemiology, pathogenesis, diagnosis, and treatment","volume":"264","author":"Eggers","year":"2017","journal-title":"Journal of Neurology"},{"issue":"52","key":"10.1016\/j.pharmthera.2021.108047_bb0285","doi-asserted-by":"crossref","first-page":"50348","DOI":"10.1074\/jbc.M207170200","article-title":"The endocannabinoid system protects rat glioma cells against HIV-1 Tat protein-induced cytotoxicity: Mechanism and regulation","volume":"277","author":"Esposito","year":"2002","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108047_bb0290","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41577-018-0005-7","article-title":"Nonhuman primate models of human viral infections","volume":"18","author":"Estes","year":"2018","journal-title":"Nature Reviews Immunology"},{"issue":"9","key":"10.1016\/j.pharmthera.2021.108047_bb0295","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1073\/pnas.0611699104","article-title":"HIV-tat induces formation of an LRP-PSD-95-NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes","volume":"104","author":"Eugenin","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108047_bb0300","first-page":"255","article-title":"Nonhuman primate models in AIDS research","volume":"8","author":"Evans","year":"2013","journal-title":"Current Opinion in HIV and AIDS"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0305","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0026-895X(25)10492-6","article-title":"Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors","volume":"48","author":"Felder","year":"1995","journal-title":"Molecular Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2021.108047_bb0310","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neubiorev.2008.01.004","article-title":"Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: Current status of dopamine system vulnerability in NeuroAIDS","volume":"32","author":"Ferris","year":"2008","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0315","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11481-016-9716-3","article-title":"Nanoformulated antiretrovirals for penetration of the central nervous system: State of the art","volume":"12","author":"Fiandra","year":"2017","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0320","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12974-016-0585-8","article-title":"Neuroprotective effects of the immunomodulatory drug FK506 in a model of HIV1-gp120 neurotoxicity","volume":"13","author":"Fields","year":"2016","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0325","article-title":"The cannabinoid receptor agonist, WIN, suppresses the activation of proinflammatory genes induced by interleukin 1 beta in human astrocytes","author":"Fields","year":"2020","journal-title":"Cannabis and Cannabinoid Research."},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0330","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuro.2006.07.014","article-title":"Neonatal intrahippocampal gp120 injection: An examination early in development","volume":"28","author":"Fitting","year":"2007","journal-title":"Neurotoxicology"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108047_bb0335","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2174\/1570162X1206150311161147","article-title":"Opiate addiction therapies and HIV-1 Tat: Interactive effects on glial [Ca2+]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity","volume":"12","author":"Fitting","year":"2014","journal-title":"Current HIV Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0340","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/exnr.2002.8048","article-title":"Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain","volume":"179","author":"Flora","year":"2003","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0345","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2334-11-356","article-title":"The definition of HIV-associated neurocognitive disorders: Are we overestimating the real prevalence?","volume":"11","author":"Gissl\u00e9n","year":"2011","journal-title":"BMC Infectious Diseases"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0350","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tins.2011.12.006","article-title":"Rodent models for HIV-associated neurocognitive disorders","volume":"35","author":"Gorantla","year":"2012","journal-title":"Trends in Neurosciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108047_bb0355","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1046\/j.1471-4159.1999.0731363.x","article-title":"Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein Tat","volume":"73","author":"Haughey","year":"1999","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0360","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","article-title":"HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors","volume":"17","author":"Heaton","year":"2011","journal-title":"Journal of Neurovirology"},{"issue":"10","key":"10.1016\/j.pharmthera.2021.108047_bb0365","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","article-title":"Microglia in neurodegeneration","volume":"21","author":"Hickman","year":"2018","journal-title":"Nature Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0370","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11481-019-09846-1","article-title":"Chronic intrahippocampal infusion of HIV-1 neurotoxic proteins: A novel mouse model of HIV-1 associated inflammation and neural stem cell dysfunction","volume":"14","author":"Hill","year":"2019","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0375","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1529-8027.2009.00203.x","article-title":"GPI-1046 protects dorsal root ganglia from gp120-induced axonal injury by modulating store-operated calcium entry","volume":"14","author":"H\u00f6ke","year":"2009","journal-title":"Journal of the Peripheral Nervous System"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2014.10.008","article-title":"Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications","volume":"45","author":"Hong","year":"2015","journal-title":"Brain, Behavior, and Immunity"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0385","first-page":"85","article-title":"A novel concept is needed for combating Alzheimer\u2019s disease and NeuroHIV","volume":"4","author":"Hu","year":"2020","journal-title":"Alzheimers Disease & Dementia"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108047_bb0390","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/jcbfm.2013.240","article-title":"PPAR agonist-mediated protection against HIV Tat-induced cerebrovascular toxicity is enhanced in MMP-9-deficient mice","volume":"34","author":"Huang","year":"2014","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"issue":"42","key":"10.1016\/j.pharmthera.2021.108047_bb0395","doi-asserted-by":"crossref","first-page":"15195","DOI":"10.1523\/JNEUROSCI.2051-11.2011","article-title":"Glutaminase dysregulation in HIV-1-infected human microglia mediates neurotoxicity: Relevant to HIV-1-associated neurocognitive disorders","volume":"31","author":"Huang","year":"2011","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0400","doi-asserted-by":"crossref","first-page":"8910396","DOI":"10.1155\/2016\/8910396","article-title":"Oxidative stress during HIV infection: Mechanisms and consequences","volume":"2016","author":"Ivanov","year":"2016","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108047_bb0405","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11481-019-09867-w","article-title":"Inhibitory control deficits associated with upregulation of CB(1)R in the HIV-1 Tat transgenic mouse model of hand","volume":"14","author":"Jacobs","year":"2019","journal-title":"Journal of Neuroimmune Pharmacology\u202f: The Official Journal of the Society on NeuroImmune Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108047_bb0410","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.intimp.2013.07.013","article-title":"Phytoestrogens mediated anti-inflammatory effect through suppression of IRF-1 and pSTAT1 expressions in lipopolysaccharide-activated microglia","volume":"17","author":"Jantaratnotai","year":"2013","journal-title":"International Immunopharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108047_bb0415","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s13365-017-0538-8","article-title":"Novel nanoformulation to mitigate co-effects of drugs of abuse and HIV-1 infection: Towards the treatment of NeuroAIDS","volume":"23","author":"Jayant","year":"2017","journal-title":"Journal of Neurovirology"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-31285-w","article-title":"Multifunctional nanotherapeutics for the treatment of neuroAIDS in drug abusers","volume":"8","author":"Jayant","year":"2018","journal-title":"Scientific Reports"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2021.108047_bb0425","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/00002030-199101001-00006","article-title":"Pathogenesis of AIDS: The non-human primate model","volume":"5","author":"Johnson","year":"1991","journal-title":"AIDS"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0430","first-page":"2","article-title":"Determination of mitochondrial membrane potential and reactive oxygen species in live rat cortical neurons","volume":"51","author":"Joshi","year":"2011","journal-title":"Journal of Visualized Experiments"},{"issue":"14","key":"10.1016\/j.pharmthera.2021.108047_bb0435","doi-asserted-by":"crossref","first-page":"8212","DOI":"10.1073\/pnas.96.14.8212","article-title":"Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis","volume":"96","author":"Kaul","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2021.108047_bb0440","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/sj.cdd.4401623","article-title":"HIV-1 infection and AIDS: Consequences for the central nervous system","volume":"12","author":"Kaul","year":"2005","journal-title":"Cell Death and Differentiation"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0445","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/WCO.0b013e328329cf3c","article-title":"HIV-1 associated dementia: Update on pathological mechanisms and therapeutic approaches","volume":"22","author":"Kaul","year":"2009","journal-title":"Current Opinion in Neurology"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-6-40","article-title":"Gonadal steroids differentially modulate neurotoxicity of HIV and cocaine: Testosterone and ICI 182, 780 sensitive mechanism","volume":"6","author":"Kendall","year":"2005","journal-title":"BMC Neuroscience"},{"issue":"11","key":"10.1016\/j.pharmthera.2021.108047_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12111059","article-title":"Boosting the brain delivery of Atazanavir through nanostructured lipid carrier-based approach for mitigating neuroaids","volume":"12","author":"Khan","year":"2020","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0460","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1124\/mol.111.071647","article-title":"Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss","volume":"80","author":"Kim","year":"2011","journal-title":"Molecular Pharmacology"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2021.108047_bb0465","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejphar.2006.05.025","article-title":"AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis","volume":"542","author":"Kim","year":"2006","journal-title":"European Journal of Pharmacology"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2021.108047_bb0470","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0165-5728(98)00223-9","article-title":"Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10","volume":"93","author":"Kolb","year":"1999","journal-title":"Journal of Neuroimmunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108047_bb0475","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1006\/exnr.1998.6958","article-title":"HIV-1 protein tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress","volume":"154","author":"Kruman","year":"1998","journal-title":"Experimental Neurology"},{"issue":"11","key":"10.1016\/j.pharmthera.2021.108047_bb0480","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1111\/j.1460-9568.1995.tb00649.x","article-title":"HIV-1 envelope proteins gp120 and gp160 potentiate NMDA-induced [Ca2+]i increase, Alter [Ca2+]i homeostasis and induce neurotoxicity in human embryonic neurons","volume":"7","author":"Lannuzel","year":"1995","journal-title":"European Journal of Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-015-0390-9","article-title":"Lack of neuroinflammation in the HIV-1 transgenic rat: An [18F]-DPA714 PET imaging study","volume":"12","author":"Lee","year":"2015","journal-title":"Journal of Neuroinflammation"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108047_bb0490","first-page":"45","article-title":"Neurologic complications of HIV disease and their treatment","volume":"18","author":"Letendre","year":"2010","journal-title":"Topics in HIV Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108047_bb0495","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s13365-020-00871-y","article-title":"Correction to: A candidate gene study of intermediate histopathological phenotypes in HIV-associated neurocognitive disorders (Journal of NeuroVirology, (2020), 26, 4, (496-508), 10.1007\/s13365-020-00846-z)","volume":"26","author":"Levine","year":"2020","journal-title":"Journal of Neurovirology"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0500","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/123605","article-title":"Impact of tat genetic variation on HIV-1 disease","author":"Li","year":"2012","journal-title":"Advances in Virology"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0505","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1750-3639.1991.tb00659.x","article-title":"HIV-related neurotoxicity","volume":"1","author":"Lipton","year":"1991","journal-title":"Brain Pathology (Zurich, Switzerland)"},{"issue":"12","key":"10.1016\/j.pharmthera.2021.108047_bb0510","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/82199","article-title":"Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands","volume":"6","author":"Liu","year":"2000","journal-title":"Nature Medicine"},{"issue":"12","key":"10.1016\/j.pharmthera.2021.108047_bb0515","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/82199","article-title":"Uptake of HIV-1 Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands","volume":"6","author":"Liu","year":"2000","journal-title":"Nature Medicine"},{"issue":"23","key":"10.1016\/j.pharmthera.2021.108047_bb0520","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/sj.gt.3303030","article-title":"Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors","volume":"14","author":"Louboutin","year":"2007","journal-title":"Gene Therapy"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0525","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.expneurol.2009.11.004","article-title":"HIV-1 gp120-induced neuroinflammation: Relationship to neuron loss and protection by rSV40-delivered antioxidant enzymes","volume":"221","author":"Louboutin","year":"2010","journal-title":"Experimental Neurology"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0530","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.expneurol.2009.11.004","article-title":"HIV-1 gp120-induced neuroinflammation: Relationship to neuron loss and protection by rSV40-delivered antioxidant enzymes","volume":"221","author":"Louboutin","year":"2010","journal-title":"Experimental Neurology"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108047_bb0535","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/antiox3040770","article-title":"Role of oxidative stress in HIV-1-associated neurocognitive disorder and protection by gene delivery of antioxidant enzymes","volume":"3","author":"Louboutin","year":"2014","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108047_bb0540","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4062\/biomolther.2014.036","article-title":"The protective effects of IGF-1 on different subpopulations of DRG neurons with neurotoxicity induced by gp120 and dideoxycytidine in vitro","volume":"22","author":"Lu","year":"2014","journal-title":"Biomolecules & Therapeutics"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108047_bb0545","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1046\/j.1471-4159.2002.01212.x","article-title":"Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function","volume":"83","author":"Maragos","year":"2002","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0550","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13181-013-0325-8","article-title":"A review of the toxicity of HIV medications","volume":"10","author":"Margolis","year":"2014","journal-title":"Journal of Medical Toxicology"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0555","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mcn.2015.01.001","article-title":"GSK3\u03b2-activation is a point of convergence for HIV-1 and opiate-mediated interactive neurotoxicity","volume":"65","author":"Masvekar","year":"2015","journal-title":"Molecular and Cellular Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108047_bb0560","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13365-017-0544-x","article-title":"Evolution of the HIV-1 transgenic rat: Utility in assessing the progression of HIV-1-associated neurocognitive disorders","volume":"24","author":"McLaurin","year":"2018","journal-title":"Journal of Neurovirology"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0570","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3389\/fmicb.2015.01164","article-title":"The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders","volume":"6","author":"Mediouni","year":"2015","journal-title":"Frontiers in Microbiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108047_bb0575","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1084\/jem.20041196","article-title":"Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract","volume":"200","author":"Mehandru","year":"2004","journal-title":"Journal of Experimental Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0580","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1124\/pr.111.005553","article-title":"The dual role of pharmacogenetics in HIV treatment: Mutations and polymorphisms regulating antiretroviral drug resistance and disposition","volume":"64","author":"Michaud","year":"2012","journal-title":"Pharmacological Reviews"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108047_bb0585","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.bjp.0707523","article-title":"CB 2 receptor-mediated migration of immune cells: It can go either way","volume":"153","author":"Miller","year":"2008","journal-title":"British Journal of Pharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2021.108047_bb0590","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10081018","article-title":"Advances in siv\/shiv non-human primate models of neuroaids","volume":"10","author":"Moretti","year":"2021","journal-title":"Pathogens"},{"issue":"8","key":"10.1016\/j.pharmthera.2021.108047_bb0595","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1371\/journal.pmed.0050173","article-title":"The use of nonhuman primate models in HIV vaccine development","volume":"5","author":"Morgan","year":"2008","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0600","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3389\/fimmu.2019.02445","article-title":"The effects of opioids on HIV Neuropathogenesis","volume":"10","author":"Murphy","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108047_bb0605","first-page":"280","article-title":"Directing the antiretroviral drugs to the brain reservoir: A nanoformulation approach for NeuroAIDS","volume":"22","author":"Nabi","year":"2021","journal-title":"Current Drug Metabolism"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108047_bb0610","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/1531-8249(200002)47:2<186::AID-ANA8>3.0.CO;2-3","article-title":"Synergistic neurotoxicity by human immunodeficiency virus proteins tat and gp120: Protection by memantine","volume":"47","author":"Nath","year":"2000","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0615","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/jvi.70.3.1475-1480.1996","article-title":"Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic","volume":"70","author":"Nath","year":"1996","journal-title":"Journal of Virology"},{"issue":"9","key":"10.1016\/j.pharmthera.2021.108047_bb0620","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0966-842X(00)01816-3","article-title":"The chimpanzee and other non-human-primate models in HIV-1 vaccine research","volume":"8","author":"Nath","year":"2000","journal-title":"Trends in Microbiology"},{"issue":"January","key":"10.1016\/j.pharmthera.2021.108047_bb0625","article-title":"Treating viruses in the brain: Perspectives from NeuroAIDS","volume":"748","author":"Nicol","year":"2021","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0630","series-title":"Drugs of abuse, immunomodulation, and aids","first-page":"223","article-title":"Cannabinoid receptor agonists enhance syncytia formation in MT-2 cells infected with cell free HIV-1MN","author":"Noe","year":"1998"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0635","doi-asserted-by":"crossref","first-page":"17061","DOI":"10.1038\/cddiscovery.2017.61","article-title":"HIV-1-associated inflammation and antiretroviral therapy regulate astrocyte endoplasmic reticulum stress responses","volume":"3","author":"Nooka","year":"2017","journal-title":"Cell Death Discovery"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0640","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12974-014-0214-3","article-title":"Molecular mechanisms involved in HIV-1 Tat-mediated induction of IL-6 and IL-8 in astrocytes","volume":"11","author":"Nookala","year":"2014","journal-title":"Journal of Neuroinflammation"},{"issue":"May 2018","key":"10.1016\/j.pharmthera.2021.108047_bb0645","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbi.2018.04.018","article-title":"Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors","volume":"71","author":"Nookala","year":"2018","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0650","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fnins.2015.00069","article-title":"Methamphetamine effects on blood-brain barrier structure and function","volume":"9","author":"Northrop","year":"2015","journal-title":"Frontiers in Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108047_bb0655","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s11481-010-9198-7","article-title":"Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: Implications for NeuroAIDS therapeutics","volume":"5","author":"Nowacek","year":"2010","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0660","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11481-020-09916-9","article-title":"The messenger apps of the cell: Extracellular vesicles as regulatory messengers of microglial function in the CNS","volume":"15","author":"Olanrewaju","year":"2020","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0665","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/bbrc.2000.3113","article-title":"Immediate and neurotoxic effects of HIV protein gp120 act through CXCR4 receptor","volume":"274","author":"Pandey","year":"2000","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"5","key":"10.1016\/j.pharmthera.2021.108047_bb0670","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.yhbeh.2014.04.001","article-title":"Progesterone protects normative anxiety-like responding among ovariectomized female mice that conditionally express the HIV-1 regulatory protein, Tat, in the CNS","volume":"65","author":"Paris","year":"2014","journal-title":"Hormones and Behavior"},{"issue":"42","key":"10.1016\/j.pharmthera.2021.108047_bb0675","doi-asserted-by":"crossref","first-page":"14153","DOI":"10.1523\/JNEUROSCI.1042-10.2010","article-title":"Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax","volume":"30","author":"Perry","year":"2010","journal-title":"Journal of Neuroscience"},{"issue":"Suppl 1(Suppl 1)","key":"10.1016\/j.pharmthera.2021.108047_bb0680","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.bbi.2011.03.001","article-title":"HIV-1 infection and alcohol abuse: Neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions","volume":"25","author":"Persidsky","year":"2011","journal-title":"Brain, Behavior, and Immunity"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0685","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainresrev.2005.04.002","article-title":"HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations","volume":"50","author":"Pocernich","year":"2005","journal-title":"Brain Research Reviews"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0690","article-title":"Genetic profile, environmental exposure, and their interaction in Parkinson\u2019s disease","author":"Polito","year":"2016","journal-title":"Parkinson\u2019s Disease, 2016"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0695","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ebiom.2016.01.028","article-title":"Reversing gut damage in HIV infection: Using non-human primate models to instruct clinical research","volume":"4","author":"Ponte","year":"2016","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108047_bb0700","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3940(98)00058-5","article-title":"Toxic effects of \u03b2-amyloid (25\u201335) on immortalised rat brain endothelial cell: Protection by carnosine, homocarnosine and \u03b2-alanine","volume":"242","author":"Preston","year":"1998","journal-title":"Neuroscience Letters"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2021.108047_bb0705","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainres.2005.03.031","article-title":"HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells","volume":"1045","author":"Price","year":"2005","journal-title":"Brain Research"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2021.108047_bb0710","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0006-8993(00)03293-5","article-title":"CPI-1189 attenuates effects of suspected neurotoxins associated with AIDS dementia: A possible role for ERK activation","volume":"893","author":"Pulliam","year":"2001","journal-title":"Brain Research"},{"issue":"12","key":"10.1016\/j.pharmthera.2021.108047_bb0715","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/jcbfm.2009.112","article-title":"Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells","volume":"29","author":"Ramirez","year":"2009","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108047_bb0720","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1177\/0960327120975448","article-title":"Cannabinoid CB1 receptor mediates METH-induced electrophysiological and morphological alterations in cerebellum Purkinje cells","volume":"40","author":"Ramshini","year":"2021","journal-title":"Human & Experimental Toxicology"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0725","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-6405-11-13","article-title":"Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND)","volume":"11","author":"Rao","year":"2014","journal-title":"AIDS Research and Therapy"},{"issue":"33","key":"10.1016\/j.pharmthera.2021.108047_bb0730","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1523\/JNEUROSCI.0226-17.2017","article-title":"A GluN2B-selective NMDAR antagonist reverses synapse loss and cognitive impairment produced by the HIV-1 protein tat","volume":"37","author":"Raybuck","year":"2017","journal-title":"Journal of Neuroscience"},{"issue":"5","key":"10.1016\/j.pharmthera.2021.108047_bb0735","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuint.2011.06.011","article-title":"HIV-1 gp120 induces antioxidant response element-mediated expression in primary astrocytes: Role in HIV associated neurocognitive disorder","volume":"61","author":"Reddy","year":"2012","journal-title":"Neurochemistry International"},{"issue":"16","key":"10.1016\/j.pharmthera.2021.108047_bb0740","doi-asserted-by":"crossref","first-page":"9271","DOI":"10.1073\/pnas.161290298","article-title":"An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction","volume":"98","author":"Reid","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0745","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0152265","article-title":"Neurobehavioral abnormalities in the HIV-1 transgenic rat do not correspond to neuronal hypometabolism on 18F-FDG-PET","volume":"11","author":"Reid","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0750","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0074-7742(07)82016-2","article-title":"Oxidative stress and the pathogenesis of neurodegenerative disorders","volume":"82","author":"Reynolds","year":"2007","journal-title":"International Review of Neurobiology"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0755","doi-asserted-by":"crossref","DOI":"10.1007\/s11481-020-09918-7","article-title":"Targeting cannabinoid receptor 2 on peripheral leukocytes to attenuate inflammatory mechanisms implicated in HIV-associated neurocognitive disorder","author":"Rizzo","year":"2020","journal-title":"Journal of Neuroimmune Pharmacology\u202f: The Official Journal of the Society on NeuroImmune Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2021.108047_bb0760","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s13365-012-0120-3","article-title":"Antiretroviral neurotoxicity","volume":"18","author":"Robertson","year":"2012","journal-title":"Journal of Neurovirology"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0765","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11481-018-9794-5","article-title":"Dimethyl fumarate prevents HIV-induced lysosomal dysfunction and cathepsin B release from macrophages","volume":"13","author":"Rosario-Rodr\u00edguez","year":"2018","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0770","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0896-6273(00)80086-0","article-title":"Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate","volume":"16","author":"Rothstein","year":"1996","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0775","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0896-6273(94)90038-8","article-title":"Localization of neuronal and glial glutamate transporters","volume":"13","author":"Rothstein","year":"1994","journal-title":"Neuron"},{"issue":"JUN","key":"10.1016\/j.pharmthera.2021.108047_bb0780","first-page":"1","article-title":"Neuroinflammation and behavior in HIV-1 transgenic rats exposed to chronic adolescent stress","volume":"7","author":"Rowson","year":"2016","journal-title":"Frontiers in Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108047_bb0785","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1750-3639.2004.tb00084.x","article-title":"Endothelins negatively regulate glial glutamate transporter expression","volume":"14","author":"Rozyczka","year":"2004","journal-title":"Brain Pathology (Zurich, Switzerland)"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0790","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-017-0013-6","article-title":"Human immunodeficiency virus Tat impairs mitochondrial fission in neurons","volume":"4","author":"Rozzi","year":"2018","journal-title":"Cell Death Discovery"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108047_bb0795","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s12640-017-9776-z","article-title":"Human immunodeficiency virus promotes mitochondrial toxicity","volume":"32","author":"Rozzi","year":"2017","journal-title":"Neurotoxicity Research"},{"issue":"42","key":"10.1016\/j.pharmthera.2021.108047_bb0800","doi-asserted-by":"crossref","first-page":"8408","DOI":"10.1523\/JNEUROSCI.2851-18.2019","article-title":"Microglia mediate HIV-1 gp120-induced synaptic degeneration in spinal pain neural circuits","volume":"39","author":"Ru","year":"2019","journal-title":"Journal of Neuroscience"},{"issue":"5","key":"10.1016\/j.pharmthera.2021.108047_bb0805","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.neuro.2005.01.009","article-title":"17\u03b2-estradiol protects SH-SY5Y cells against HIV-1 gp120-induced cell death: Evidence for a role of estrogen receptors","volume":"26","author":"Russo","year":"2005","journal-title":"NeuroToxicology"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0810","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci7030025","article-title":"Neuronal stress and injury caused by HIV-1, cART and drug abuse: Converging contributions to HAND","volume":"7","author":"Sanchez","year":"2017","journal-title":"Brain Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0815","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/AAC.01632-15","article-title":"Antiretrovirals, methamphetamine, and HIV-1 envelope protein gp120 compromise neuronal energy homeostasis in association with various degrees of synaptic and Neuritic damage","volume":"60","author":"Sanchez","year":"2016","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0820","first-page":"1","article-title":"Modulation of excitatory synaptic transmission during cannabinoid receptor activation","volume":"1","author":"Savchenko","year":"2021","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108047_bb0825","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","article-title":"HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nature Reviews Neurology"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108047_bb0830","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/brainsci7040038","article-title":"The role of HIV infection in neurologic injury","volume":"7","author":"Scutari","year":"2017","journal-title":"Brain Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108047_bb0835","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/QAD.0b013e328340fd42","article-title":"Editorial NeuroAIDS review","volume":"25","author":"Shapshak","year":"2011","journal-title":"Aids"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108047_bb0840","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/138920021602150713114715","article-title":"Physical and metabolic integrity of the blood-brain barrier in HIV infection: A special focus on intercellular junctions, influx and efflux transporters and metabolizing enzymes","volume":"16","author":"Shawahna","year":"2015","journal-title":"Current Drug Metabolism"},{"issue":"5","key":"10.1016\/j.pharmthera.2021.108047_bb0845","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/157016212802138724","article-title":"HIV-1 gp120 and drugs of abuse: Interactions in the central nervous system","volume":"10","author":"Silverstein","year":"2012","journal-title":"Current HIV Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108047_bb0850","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2174\/1570162X16666181003144740","article-title":"HIV associated neurodegenerative disorders: A new perspective on the role of lipid rafts in Gp120-mediated neurotoxicity","volume":"16","author":"Smith","year":"2018","journal-title":"Current HIV Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0855","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11481-006-9060-0","article-title":"Neuroprotective and antiretroviral effects of the immunophilin ligand GPI 1046","volume":"2","author":"Steiner","year":"2007","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"18","key":"10.1016\/j.pharmthera.2021.108047_bb0860","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1523\/JNEUROSCI.1280-17.2018","article-title":"BACE1 mediates HIV-associated and excitotoxic neuronal damage through an APP-dependent mechanism","volume":"38","author":"Stern","year":"2018","journal-title":"The Journal of Neuroscience"},{"issue":"10","key":"10.1016\/j.pharmthera.2021.108047_bb0865","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1111\/j.1460-9568.2006.04813.x","article-title":"Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3\u03b2 to antagonize nuclear factor-\u03baB survival pathway in neurons","volume":"23","author":"Sui","year":"2006","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0870","doi-asserted-by":"crossref","DOI":"10.1155\/2007\/23513","article-title":"Cannabinoids: A new group of agonists of PPARs","volume":"2007","author":"Sun","year":"2007","journal-title":"PPAR Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2021.108047_bb0875","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0973-7847.79098","article-title":"Phytoestrogens in postmenopausal indications: A theoretical perspective","volume":"5","author":"Sunita","year":"2011","journal-title":"Pharmacognosy Reviews"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0880","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nature Reviews. Neurology"},{"issue":"May","key":"10.1016\/j.pharmthera.2021.108047_bb0885","article-title":"Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia","volume":"130","author":"Swinton","year":"2019","journal-title":"Neurobiology of Disease"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108047_bb0890","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/jnc.12953","article-title":"Astrocytes mediate HIV-1 Tat-induced neuronal damage via ligand-gated ion channel P2X7R","volume":"132","author":"Tewari","year":"2015","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0895","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-2-3","article-title":"Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine","volume":"2","author":"Turchan","year":"2001","journal-title":"BMC Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0900","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/QAD.0000000000000538","article-title":"Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?","volume":"29","author":"Underwood","year":"2015","journal-title":"AIDS (London, England)"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108047_bb0905","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1189\/jlb.0809571","article-title":"HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications","volume":"87","author":"Valcour","year":"2010","journal-title":"Journal of Leukocyte Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0910","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1089\/aid.2011.0234","article-title":"The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies","volume":"28","author":"Van Rompay","year":"2012","journal-title":"AIDS Research and Human Retroviruses"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108047_bb0915","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/laban.1279","article-title":"Tackling HIV and AIDS: Contributions by non-human primate models","volume":"46","author":"Van Rompay","year":"2017","journal-title":"Lab Animal"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0920","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/1061186X.2017.1374389","article-title":"Nanocarriers for brain specific delivery of anti-retro viral drugs: Challenges and achievements","volume":"26","author":"Varghese","year":"2018","journal-title":"Journal of Drug Targeting"},{"issue":"5362","key":"10.1016\/j.pharmthera.2021.108047_bb0925","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1126\/science.280.5362.427","article-title":"Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection","volume":"280","author":"Veazey","year":"1998","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108047_bb0930","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ilar\/ilx032","article-title":"Nonhuman primate models and understanding the pathogenesis of HIV infection and AIDS","volume":"58","author":"Veazey","year":"2017","journal-title":"ILAR Journal"},{"issue":"11","key":"10.1016\/j.pharmthera.2021.108047_bb0935","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S1471-4906(01)02039-7","article-title":"The mucosal immune system: Primary target for HIV infection and AIDS","volume":"22","author":"Veazey","year":"2001","journal-title":"Trends in Immunology"},{"issue":"30","key":"10.1016\/j.pharmthera.2021.108047_bb0940","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.2174\/138161210793563518","article-title":"Pharmacogenetics of the metabolic disturbances and atherosclerosis associated with antiretroviral therapy in HIV-infected patients","volume":"16","author":"Veloso","year":"2010","journal-title":"Current Pharmaceutical Design"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb0945","first-page":"15","article-title":"Pharmacogenetics of adverse effects due to antiretroviral drugs","volume":"12","author":"Vidal","year":"2010","journal-title":"AIDS Reviews"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0950","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbi.2015.02.020","article-title":"The HIV-1 transgenic rat model of neuroHIV","volume":"48","author":"Vigorito","year":"2015","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0955","first-page":"1","article-title":"HIV neurotoxicity: Potential therapeutic interventions","volume":"2006","author":"Wallace","year":"2006","journal-title":"Journal of Biomedicine and Biotechnology"},{"key":"10.1016\/j.pharmthera.2021.108047_bb0960","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/syn.20214","article-title":"Estrogen attenuates gp120- and tat1-72-induced oxidative stress and prevents loss of dopamine transporter function","volume":"59","author":"Wallace","year":"2006","journal-title":"Synapse"},{"issue":"October","key":"10.1016\/j.pharmthera.2021.108047_bb0965","first-page":"1","article-title":"Microglial cells: The main HIV-1 reservoir in the brain","volume":"9","author":"Wallet","year":"2019","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"issue":"June","key":"10.1016\/j.pharmthera.2021.108047_bb0970","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.omtn.2018.01.012","article-title":"Generation of Hutat2:Fc Knockin primary human monocytes using CRISPR\/Cas9","volume":"11","author":"Wang","year":"2018","journal-title":"Molecular Therapy--Nucleic Acids"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0975","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4161\/auto.7.3.14502","article-title":"Mitochondria removal by autophagy","volume":"7","author":"Wang","year":"2011","journal-title":"Autophagy"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108047_bb0980","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1017\/S1355617720001447","article-title":"Daily cannabis use is associated with lower CNS inflammation in people with HIV","volume":"27","author":"Watson","year":"2021","journal-title":"Journal of the International Neuropsychology Sociiety"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb0985","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11481-017-9739-4","article-title":"Endocytic trafficking of HIV gp120 is mediated by dynamin and plays a role in gp120 neurotoxicity","volume":"12","author":"Wenzel","year":"2017","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"9","key":"10.1016\/j.pharmthera.2021.108047_bb0990","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/s41419-019-1920-7","article-title":"Histone deacetylase 6 inhibition rescues axonal transport impairments and prevents the neurotoxicity of HIV-1 envelope protein gp120","volume":"10","author":"Wenzel","year":"2019","journal-title":"Cell Death & Disease"},{"issue":"8","key":"10.1016\/j.pharmthera.2021.108047_bb0995","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1084\/jem.193.8.905","article-title":"Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: Implications for the neuropathogenesis of AIDS","volume":"193","author":"Williams","year":"2001","journal-title":"Journal of Experimental Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2021.108047_bb1000","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005709","article-title":"HIV-1 Tat co-operates with IFN-gamma and TNF-alpha to increase CXCL10 in human astrocytes","volume":"4","author":"Williams","year":"2009","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.pharmthera.2021.108047_bb1005","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/glia.20949","article-title":"Cooperative induction of CXCL10 involves NADPH oxidase: Implications for HIV dementia","volume":"58","author":"Williams","year":"2010","journal-title":"Glia"},{"issue":"7","key":"10.1016\/j.pharmthera.2021.108047_bb1010","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1016\/S2352-3018(20)30107-7","article-title":"Cognitive disorders in people living with HIV","volume":"7","author":"Winston","year":"2020","journal-title":"The Lancet HIV"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108047_bb1015","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/med.21708","article-title":"Recent advances in natural anti-HIV triterpenoids and analogs","volume":"40","author":"Wu","year":"2020","journal-title":"Medicinal Research Reviews"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb1020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/ENEURO.0119-20.2020","article-title":"Hiv tat protein selectively impairs cb1 receptor-mediated presynaptic inhibition at excitatory but not inhibitory synapses","volume":"7","author":"Wu","year":"2020","journal-title":"ENeuro"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb1025","first-page":"84","article-title":"Role of microglia in methamphetamine-induced neurotoxicity","volume":"9","author":"Xu","year":"2017","journal-title":"International Journal of Physiology, Pathophysiology and Pharmacology"},{"issue":"18","key":"10.1016\/j.pharmthera.2021.108047_bb1030","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1073\/pnas.0304859101","article-title":"HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathy","volume":"101","author":"Xu","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb1035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.taap.2014.07.010","article-title":"Celastrol ameliorates HIV-1 tat-induced inflammatory responses via NF-kappaB and AP-1 inhibition and heme oxygenase-1 induction in astrocytes","volume":"280","author":"Youn","year":"2014","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108047_bb1040","article-title":"Beneficial and adverse effects of cART affect neurocognitive function in HIV-1 infection: Balancing viral suppression against neuronal stress and injury","author":"Yuan","year":"2019","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2021.108047_bb1045","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainres.2005.03.049","article-title":"Estrogenic protection against gp120 neurotoxicity: Role of microglia","volume":"1046","author":"Zemlyak","year":"2005","journal-title":"Brain Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108047_bb1050","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0006-8993(02)03558-8","article-title":"Protection against gp120-induced neurotoxicity by an array of estrogenic steroids","volume":"958","author":"Zemlyak","year":"2002","journal-title":"Brain Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108047_bb1055","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/jnc.14640","article-title":"HIV gp120-induced neuroinflammation potentiates NMDA receptors to overcome basal suppression of inhibitory synapses by p38 MAPK","volume":"148","author":"Zhang","year":"2019","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb1060","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.intimp.2007.12.012","article-title":"Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity","volume":"8","author":"Zheng","year":"2008","journal-title":"International Immunopharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb1065","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.mcn.2004.07.003","article-title":"Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes","volume":"27","author":"Zhou","year":"2004","journal-title":"Molecular and Cellular Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108047_bb1070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12974-019-1466-8","article-title":"HIV-1 Tat enhances purinergic P2Y4 receptor signaling to mediate inflammatory cytokine production and neuronal damage via PI3K\/Akt and ERK MAPK pathways","volume":"16","author":"Zhou","year":"2019","journal-title":"Journal of Neuroinflammation"},{"issue":"11","key":"10.1016\/j.pharmthera.2021.108047_bb1075","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/syn.20949","article-title":"Recombinant human immunodeficiency virus-1 transactivator of transcription 1-86 allosterically modulates dopamine transporter activity","volume":"65","author":"Zhu","year":"2011","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108047_bb1080","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1124\/jpet.108.150144","article-title":"HIV-1 tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: Dissociation of [3H]dopamine uptake and [3H]2\u03b2-carbomethoxy-3-\u03b2-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes","volume":"329","author":"Zhu","year":"2009","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108047_bb1085","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2353\/ajpath.2007.070333","article-title":"Protection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761 involving glial fibrillary acidic protein","volume":"171","author":"Zou","year":"2007","journal-title":"The American Journal of Pathology"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821002497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821002497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:22:32Z","timestamp":1759011752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725821002497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":216,"alternative-id":["S0163725821002497"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108047","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-associated neurotoxicity and cognitive decline: Therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108047"}}